Patent details
EP2137192 Title: Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
Basic Information
- Publication number:
- EP2137192
- PCT Application Number:
- PCT/EP/2008/002929
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087352118
- PCT Publication Number:
- WO/2009/127218
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
- French Title of Invention:
- Dérivés de galantamine comme promédicaments pour le traitement de maladies du cerveau humain
- German Title of Invention:
- Galantaminderivate als Prodrug-Verbindungen zur Behandlung humaner Hirnerkrankungen
- SPC Number:
Dates
- Filing date:
- 14/04/2008
- Grant date:
- 19/02/2014
- EP Publication Date:
- 19/02/2014
- PCT Publication Date:
- 22/10/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/12/2009
- EP B1 Publication Date:
- 19/02/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/04/2014
- Expiration date:
- 14/04/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/04/2014
- Name:
- Neurodyn Life Sciences Inc.
- Address:
- Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3, Canada (CA)
Inventor
- Name:
- MAELICKE Alfred
- Address:
- Germany (DE)
Classification
- Main IPC Class:
- C07D 491/10;
Publication
European Patent Bulletin
- Issue number:
- 201745
- Publication date:
- 08/11/2017
- Description:
- Opposition rejected; Patent maintained as granted
| Filing date | Document type | Number of pages |
|---|